| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_be41078385205036f284d26d8a1a2c87 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2430-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2400-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2210-0687 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B17-12031
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-722
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-1452
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M25-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-145
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-042
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B17-12113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B17-12186 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B17-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L24-04 |
| filingDate |
2017-10-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c636513a075aed5bd7f2ee26196bd91d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dbf599556c197822bf615c7c84f031d6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d7c810be2836dac8a23d2d15a75b6080
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_263211f771597ec3d4bc8e6eeb13d98e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cf99ce41df267755b77e93972fbda9f5 |
| publicationDate |
2019-06-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-109843192-A |
| titleOfInvention |
Injectable stents and related technologies for the treatment of intracranial aneurysms |
| abstract |
A method for treating an aneurysm according to certain embodiments of the present technology includes intravascularly delivering a mixture comprising a biopolymer (eg, chitosan) and a chemical cross-linking agent (eg, genipin) to an artery tumor. The method also includes mixing the biopolymer and the chemical crosslinking agent to initiate chemical crosslinking of the biopolymer. While the chemical cross-linking is in progress, the mixture is delivered to the aneurysm through the lumen and outlet of the catheter. The mixture exits the catheter as a single viscous thread that at least partially agglomerates to form a substance that occupies at least 75% of the total interior volume of the aneurysm. During delivery of the mixture, the method includes expanding a tubular shunt to strengthen the neck of the aneurysm. |
| priorityDate |
2016-10-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |